UBS keeps Buy on EQT and Teradyne, lowers price targets
UBS keeps Buy ratings on EQT and Teradyne but trims price targets to $74 and $430, according to Dow Jones Newswires citing Benzinga data.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
UBS has kept its Buy rating on EQT Corp, the natural gas producer, while trimming its price target to $74.00 a share from $75.00. The same broker also maintained a Buy rating on Teradyne, the chip-testing equipment maker, and lowered its target to $430.00 from $485.00.
The details were reported by Dow Jones Newswires, citing ratings data from Benzinga.
why it matters
Changes of this size are routine and usually reflect small shifts in analysts' models rather than new company news. The Buy ratings stay in place, so the broker's stance is unchanged even though its valuation estimates moved slightly.
tags
instruments
sources
- EQT Corp Is Maintained at Buy by UBS — Dow Jones Newswires, 29 October 2026 at 18:43 UTC
- Teradyne Is Maintained at Buy by UBS — Dow Jones Newswires, 29 October 2026 at 18:56 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗